Geron
GERN
#5855
Rank
S$1.29 B
Marketcap
S$2.02
Share price
-1.25%
Change (1 day)
-12.75%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -S$60.87 Million

According to Geron's latest financial reports the company's current earnings are S$0.18 Billion. In 2024 the company made an earning of -S$0.2 Billion, an increase over its 2023 earnings that were of -S$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$60.87 Million-69.56%
2024 -S$0.2 Billion-11.23%
2023 -S$0.23 Billion30.22%
2022 -S$0.18 Billion20.15%
2021 -S$0.15 Billion50.08%
2020 -S$95.94 Million4.46%
2019 -S$91.84 Million130.68%
2018 -S$39.82 Million8.84%
2017 -S$36.58 Million-3.08%
2016 -S$37.74 Million-22080.6%
2015 S$0.17 M-100.38%
2014 -S$45.6 Million-7.14%
2013 -S$49.11 Million
2011 -S$0.12 Billion19.04%
2010 -S$97.59 Million8.45%
2009 -S$89.99 Million-2.51%
2008 -S$92.31 Million14.65%
2007 -S$80.52 Million32.68%
2006 -S$60.68 Million25.59%
2005 -S$48.32 Million4.36%
2004 -S$46.3 Million19.73%
2003 -S$38.67 Million-15.46%
2002 -S$45.75 Million1.94%
2001 -S$44.87 Million33.59%
2000 -S$33.59 Million27.53%
1999 -S$26.34 Million63.13%
1998 -S$16.15 Million15.6%
1997 -S$13.97 Million-10.66%
1996 -S$15.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
S$12.66 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$2.03 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$88.72 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.15 B-368.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.16 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA